The Situation

In 2024, while representing an early-stage molecular diagnostics company at the BIO International Conference with Life Science Tennessee, I encountered a pattern I couldn’t stop thinking about. BIO is a conference explicitly designed to connect scientific innovation with capital and partners. Everyone in the room wants to find the next breakthrough. And what I kept experiencing was founders with genuinely remarkable innovations who couldn’t explain them to the people standing right in front of them who wanted to fund them.

The infrastructure existed. The intent existed. The translation layer didn’t.

At some point I stopped introducing myself by title and started saying: ‘I help scientists tell great stories to connect them with the partners and investors who want to support their why.’ That line sparked more enthusiastic conversation than anything I’d said all week. People kept telling me how much that skill set was needed. I filed that away.

You have to win an investor’s heart before they’ll care about your data or your dollars.

The Challenge

When I left that company in late 2025, the question wasn’t whether to consult — it was where to focus. Science communication is a broad need. Tech, engineering, therapeutics, and finance all require translation between expert and non-expert. Many people suggested I cast a wide net.

The case for specializing was more compelling than the case for breadth. My differentiator wasn’t the molecular biology degree alone — it was having lived inside a diagnostic company through a merger, a product launch, a capital raise, and a national scale-up, and having done the translation work at every one of those inflection points. Early-stage startup to pilot launch. Pilot to national rollout. Science credibility to commercial traction. That end-to-end picture can’t be replicated quickly. And the founders who needed it most were in diagnostics and biotech, where the pathway from concept to revenue is long, expensive, and unforgiving of communication failures.

The practice needed a clear position, a service model that matched how those companies actually buy, and a network that connected Data Story Strategy to the institutions those companies depend on: life science organizations, tech transfer offices, economic development entities, incubators, and capital sources.

The gap between where diagnostic science lives and where commercial buyers need it to be is the single most common reason promising innovations stall.

The Approach

Practice positioning came first. The website, brand, and service architecture were built around a specific client profile: early- to growth-stage diagnostics and biotech companies navigating the transition from scientific credibility to commercial traction. Three service tiers were developed to match where clients actually are: a 90-day foundational engagement for seed and Series A companies establishing market presence, a growth-stage engagement for companies scaling sales enablement and pipeline, and project-based engagements for specific commercialization needs.

Network development ran in parallel. Starting from an existing life science network in Tennessee, I expanded deliberately outward: fractional leadership peers, science communication and branding firms, economic development contacts, tech transfer offices at UT and Vanderbilt, and entrepreneurial infrastructure across the state — the Knoxville Entrepreneur Center, Epicenter in Memphis, CET in Nashville, and Life Science Tennessee Ventures. Each connection was pursued not for coverage but for depth: understanding what each person and organization sees, where the gaps are, and how different parts of the ecosystem connect to each other.

Trust-based roles were prioritized over attendance. Mentoring a pitch competition at the Knoxville Entrepreneur Center, volunteering as a program mentor with Life Science Tennessee Ventures, and committing to speak at Epicenter in September positioned Data Story Strategy as a participant in the ecosystem, not just a vendor trying to extract from it.

Results

Data Story Strategy launched in January 2026. Six months in, the practice has:

3 service tiers defined and positioned for distinct client stages

1 regional innovation ecosystem mapped from the inside — Knoxville/Oak Ridge, Nashville, and statewide life science infrastructure

2 trust-based program roles: pitch competition mentor (KEC) and program mentor (Life Science TN Ventures)

1 confirmed speaking engagement: Epicenter innovation center, Memphis, September 2026

The network built since January spans entrepreneurship organizations, economic development entities, the state life science organization, university tech transfer offices, and relationships from prior diagnostics and CRO work — positioning the practice at the intersection of science, capital, and market.

A fractional CMO for an early-stage diagnostic company and a Director of Innovation for a regional ecosystem are doing the same fundamental thing at different scales. Both facilitate the multi-stakeholder translation that has to happen for an innovation to move at all.

Why This Work Transfers

Launching Data Story Strategy required the same competencies it sells: identifying a specific gap in how a market is being served, defining a position with enough discipline to say no to adjacent opportunities, and building the network that makes the position credible rather than just stated.

The methodology that drives client work — step outside the product’s development and speak to the market’s implications — was applied to the practice’s own market entry. The website, brand, and service architecture were built the same way a go-to-market strategy is built for a diagnostic company: audience-first, outcome-led, with a clear answer to the question every potential client is actually asking before they ask it.

The network development work also demonstrates something that can’t be replicated by a pitch deck: genuine ecosystem fluency. Understanding who the players are, what they care about, where the gaps are, and how to move value between organizations with different cultures and interests — that’s the core competency of anyone who operates at the intersection of science, capital, and market. It was built deliberately, not incidentally.